Recently Released Market Study: Healthcare, Regulatory and Reimbursement Landscape - China

Fast Market Research recommends "Healthcare, Regulatory and Reimbursement Landscape - China" from GlobalData, now available

Logo

Williamstown, MA -- (SBWire) -- 04/23/2012 --GlobalData, Industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of China. The report identifies the key trends in the Chinese healthcare market, as well as insights on the demographics, the regulatory and reimbursement landscapes and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

China is the most populated country in the world. In 2010, the population of China was approximately 1.3 billion - approximately one-fifth of the global population. Population growth in China has been increasing with a slow growth rate due to the strict enforcement of the country's one-child policy. The decline in the population of the young working age group and increasing elderly population is a matter of concern for policy planners.

View Full Report Details and Table of Contents

The pharmaceutical industry in China was estimated at $161.8 billion in 2010 and is expected to reach approximately $466 billion by 2020 with a projected CAGR of 10.3%. The western medicine market of China in 2009 was approximately $21 billion. The medical device market size was approximately $14.8 billion in 2010 and is expected to reach approximately $38.4 billion by 2020 with a projected CAGR of 10.1%.

This positive trend in the Chinese healthcare market can be attributed primarily to -

- Increasing elderly population
- Increasing healthcare insurance coverage
- Favorable government funding for research and development
- Government initiatives for the prevention and management of chronic diseases
- Improved IPR environment
- Reduced drug evaluation and registration process timelines

Scope

The report provides information on the healthcare, regulatory and reimbursement landscapes of China. The scope includes -

- An overview of the Chinese pharmaceutical and medical devices market, including market size, market segmentation, key drivers and barriers for the market.
- Profile and SWOT analyses of the major players in the pharmaceutical and medical devices market. Major players covered for the pharmaceutical market are the Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Harbin Pharmaceutical Group, Noth China Pharmaceutical Group and the Tasly Group. Major players covered for the medical devices market are GlaxoSmithKline, Siemens Healthcare, GE Healthcare, Medtronic, F. Hoffmann-la Roche, and Philips Healthcare.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Healthcare, Regulatory and Reimbursement Landscape - Spain
- Healthcare, Regulatory and Reimbursement Landscape - Germany
- Healthcare, Regulatory and Reimbursement Landscape - Japan
- Healthcare, Regulatory and Reimbursement Landscape - Italy
- Healthcare, Regulatory and Reimbursement Landscape - UK
- Healthcare, Regulatory and Reimbursement Landscape - US
- Healthcare, Regulatory and Reimbursement Landscape - France
- Healthcare, Regulatory and Reimbursement Landscape - Brazil
- Australia Pharmaceutical Market Overview - Reforms and continued price cuts will change the healthcare landscape
- Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify

Media Relations Contact

Bill Thompson
Director of Marketing
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/138393